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ABSTRACT
Before any published Belgian law, EU Directive, and/or EU Action Plan, the donor
advocate was naturally a member of the transplantation team performing living kidney
donation. The need of donor advocacy appeared obvious with liver living donation, which
was and is still a risky procedure. Today, it is clear that the donor advocacy must not be
limited to living donation but extended to brain-dead and cardiac-dead donation.
Nevertheless, its complexity will need experienced persons in the field of organ donation










lThe gap between donor organ availability and the de-mand for transplantation is large (Fig 1) and increas-
ing all over the world. In 2010, the number of patients
awaiting renal transplantation in Belgium was 866 on
January 1, 2010 and 914 on December 31, 2010. During the
same year, 408 candidates (20%) were transplanted with
either a donor after brain death (DBD) or a donor after
cardiac death (DCD) kidney1 and 49 with a living-donor
raft (related or unrelated); as many as 28 Belgian patients
ied on the Eurotransplant waiting list in 2009.1 Indeed, the
agnitude of the disparity between donation and recipient
eed has prompted the increased use of living donors.2
During 2010, clearly, not all Belgian potential donors
progressed to organ procurement despite a low family
refusal rate. Overall,85% of families approached agree to
proceed.1 Factors influencing the family’s perception of the
donor process are numerous and include the difficulty
regarding the health care team’s change in focus from the
death of their family member to the health of an unseen
patient at some other location and worries regarding the
appearance of their loved one after donation. Many of
these and other issues are addressed by the transplantation
community.
Faced with the drive to help ill patients through trans-
plantation by shrinking the gap between organ availability
and need, the importance of protecting the rights of living
and deceased donors has been emphasized.3 It is in this
limate that donor advocacy has evolved to keep the health
are team focused on the protection and the rights of any
erson or family to donate for the good of another.3
DEFINITION OF DONOR ADVOCACY
Donor advocacy may be defined as “a process or instance of
supporting a potential or actual organ donor.”3 That pro-
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3392cess or instance protects the donor’s right to donate; it
creates a representation for the donor in the decision-
making process that occurs as part of transplantation
evaluation and completion.3 Therefore, this broad defini-
ion extends to every kind of donation, whether deceased or
iving.
Donor advocacy is not the role of devil” advocate, a false
ttitude that has grown up around the field of living
onation. Indeed, world and/or local regulations sometimes
equire transplant programs to appoint an independent
dvocacy team to evaluate, educate, and consent to all
otential living donors as part of the transplantation prog-
ess. But strict regulations only apply for living liver donors
or extrarenal organs), the background behind such legis-
ation being well known.4 Although the broad term “donor
advocacy” applies to advocacy for all donors, it is important
to realize it is most commonly associated with living dona-
tion, especially liver living donation, but need not be
confined to it.
ETHICS AND LEGAL ATTITUDES
A first step towards donor advocacy came with the Amster-
dam Forum on care of the live kidney donor.5–7 Forum
participants affirmed the necessity for live donors to receive
complete medical and psychosocial evaluation before do-
nation. They elaborated in detail acceptance limits of donor
hypertension, obesity, dyslipidemia, renal function, urine
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DONOR ADVOCACY IN BELGIUM 3393protein and blood, stone disease, and historical malignancy
that still permit live kidney donation. A great detail of
discussion focused on prevention of transmittable infectious
diseases through live kidney transplantation. Specific rec-
ommendations for screening of various viral, bacterial, and
parasitic diseases were presented as were pre- and postop-
erative donor issues.5
In view of these evolving trends in living-donor transplan-
tation, and the need for using marginal or extended-criteria
living donors, the Ethics Committee of the Transplantation
Society proposed several recommendations, including a
donor advocate:7 “To minimize the appearance of a ‘con-
ict of interest,’ transplant centers should make efforts to
nsure that the medical and psychosocial assessments and
he decision to donate incorporates health care profession-
l(s) not involved in the care of the recipient. The intent of
his recommendation is to provide a health care profes-
ional advocating for the welfare of the potential donor.
rocedural safeguards should be used and explored to
inimize coercion and enhance autonomous decision mak-
ng, for example, by a ‘cooling off period’ and assessment of
onor retention of information.”7
A second step was undertaken at the Vancouver Forum.8
Emerging data pertaining to the aggregate risks and bene-
fits of live lung, liver, pancreas, and intestine transplanta-
tion provided more information regarding the factors that
enter into the ethical decision to place a healthy person in
harms’ way.8 The limited availability of information about
utcomes for the donors and recipients mandated that live
ung, liver, pancreas, and intestine organ donation and
ransplantation must proceed with thoughtful independent
versight and transparency. Because organs recovered from
eceased donors offer substantial (and sometimes superior)
enefits to potential recipients, with no risk to a healthy live
Fig 1. Dynamics of the Eurotransplant kidney transponor, efforts to maximize the use of organs from deceasedonors must not be impeded by the development of live
rgan donation.
Therefore, a consensus statement came from the delib-
rations of the Ethics Group of the Vancouver Forum9
defining responsibilities of the transplant team performing
all kinds of living donation.9 They must implement proce-
ural safeguards to enhance donor understanding, safety,
nd autonomous decision making. These were considered
o be essential to the process of live organ donation,
articularly for live lung, liver, pancreas, and intestine
onors.
he essential procedural components included:
nclusion of health care professionals in the donation
process who are exclusively responsible for the donor’s
evaluation and welfare. Such an individual should not
have direct contact with the recipient or be overtly
influenced by concerns for the recipient.
epetition of the information pertaining to live donation, in
recognition that informed consent is a process, not an
event.
sychosocial evaluation, to include the capacity of the
donor to process information and give informed consent.
dditional safeguards may include:
eflection period after medical acceptance and decision to
donate.
ssessment of donor retention of information and under-
standing.
xternal review committees, ie, donor advocacy.
A final ethical step came with the Declaration of Istanbul
n Organ Trafficking and Transplant Tourism.10 To ensure
the protection and safety of living donors and appropriate
recognition for their heroic act while combating transplant
tourism, organ trafficking, and transplant commercialism,
waiting list and transplants between 1969 and 2009.several strategies were suggested: among them, the deter-
23394 SQUIFFLETmination of the medical and psychosocial suitability of the
living donor, as guided by the recommendations of the
Amsterdam and Vancouver Forums. It is emphasized that
all donors should undergo psychosocial evaluation by men-
tal health professionals during screening, and that psycho-
social service should be offered as a standard component of
follow-up.10
Thus the potential for coercion, lack of respect for
patient autonomy, and perception of incompleteness of
informed consent throughout medicine and specifically in
the field of transplantation were identified. The purpose of
establishing donor advocacy paradigms and infrastructure
was the consequence of addressing such abuse potential.
The legal aspect in European Directive 210/45/EU11
pertains to standards of quality and safety of human organs
intended for transplantation. Therefore donor protection,
selection, and evaluation rules are based only on quality and
safety aspects of living donation. Action Plan 2009-201512
aims to promote altruistic donation programs and the
development of registration practices regarding living do-
nors to assess and guarantee their safety. The Commission
will also help to develop adequate tools to facilitate the
proper collection of information on the medical, psychoso-
cial, financial, and social consequences of a living donation,
in the short and the long term. This information, coupled
with the exchange of best practices on living donation
programs among the member states, should help to develop
evidence-based guidelines and consensus documents, and
address the selection, evaluation, and follow-up of the living
donor. Registers of living donors should be established to
facilitate monitoring and follow-up.12
In Belgium, the act on organ donation and transplanta-
tion (June 13, 1986)13 was modified by an act of February
5, 2007,14 which address the advocacy team in article 5
(original article 8 bis): “Any procurement from living
donors must be submitted to preliminary multidisciplinary
consultation” (in French: Tout prélèvement sur des per-
sonnes vivantes doit faire l’objet d’une concertation pluri-
disciplinaire préalable”). So far, application modalities are
not yet defined but could lead to a restrictive approach of
the donor advocacy role.
DONOR ADVOCACY AND THE DECEASED DONOR
In Belgium, the law on organ donation and transplantation
based on the presumed consent principle (opting-out sys-
tem) is not sufficient authority allowing the removal of
organs after death except for those who made a positive
declaration at the national registry during their life. For
those who did not make any decision during their life, even
if they are presumed to be in favor of organ donation,
patient rights law, transparency, and common sense require
informing family members. In these circumstances, experi-
ence confirms that the family’s collective emotion is often
not unified. Indeed the refusal rate was as much as 15% in
2009.1Here, again, the donor advocate could be of great use in
the process. An advocacy team may play a central role in
discussing with the family the donor’s willingness and
capacity to donate as indicated by the Belgian law. Its role
could be more accurate with the development of organ
procurement in DCD. The advocacy team may also help to
keep the focus on the donor’s rights. The team may
continue to answer the family’s questions as the time to
donation proceeds.
There are also situations where staff attitudes may benefit
from the assistance of a donor advocacy team. Indeed, it is
important to keep in mind that staff may have strong
feelings of distress regarding the procurement process,
especially for DCD. The advocacy team may take the time
to provide in-services, material, and resources to indicate
the true nature of a donor’s choice. That last role is of
particular interest in Belgium with organ procurement after
euthanasia.
DONOR ADVOCACY AND THE LIVING DONOR
Based on the ethical guidelines of the Amsterdam and
Vancouver Forums, the Declaration of Istanbul, the Euro-
pean Directive and Action Plan, and Belgian acts, the donor
advocate holds a particularly important job. It includes:
● Advising the donor of the risks of the procedure.
● Avoiding pressuring the potential donor to consent to the
gift.
● Ensuring more complete donor information in the diffi-
cult climate left by minimal precedent.
● Creating true informed consent in a time of what is often
family crisis.
● Exploring donors’ questions, feelings, and motivation
regarding the decision.
● Explaining, to patients who are eligible to donate, spec-
ified and unspecified donation and direct and indirect
donation.15
● Serving as a useful contact for further discussion with
family.
● Helping to improve variables such as medical mistrust,
bodily integrity, and religiosity.
Donor advocacy, when independent of transplantation staff,
more optimally avoids a potential conflict of interest.
Moreover, many argue that ethical issues related to simul-
taneous involvement with both donors and recipients, in
addition to a need to ensure confidentiality, is another
supporting cause for the provision of separate care provid-
ers for donors and recipients.
DONOR ADVOCACY AND THE FUTURE
Living-donor transplantation started in Belgium before any
Belgian acts or EU directives/action plans and without
donor advocacy. All living-donor kidney recipient pairs
were referred by local nephrologists to the transplant center
team. The latter included nephrologists, transplant sur-










DONOR ADVOCACY IN BELGIUM 3395request. Throughout the process until the day of transplan-
tation, information was given to all pairs through leaflets,
booklets, websites, consultations, and good sense practice.
The aim was to assure quality and safety, assess the freedom
of the act, and avoid coercion. Strict criteria for living donor
selection were applied, and today, data confirm that kidney
donor life expectancy is still greater compared with the
general population. All kidney transplant candidates, who
could not get a live-donor graft, were put on the Eurotrans-
plant cadaver waiting list.
Owing to the fact that DBD and DCD rates cannot be
increased and the quality of grafted organs is decreasing, there
is a need to use more marginal donors and relax the selective
criteria for living donation. Meanwhile, living liver donation
was proposed to spare DCD liver grafts for recipients who
could not fulfil the usual criteria for transplantation. Indeed
living liver donation is a more risky procedure compared with
living kidney donation, with increasedmorbidity andmortality.
Moreover, due to emergency situations, the decision to donate
must be undertaken within a few hours without any cooling off
period or information brought by the transplantation team.
Therefore, it became obvious that in these circumstances there
is a need for a donor advocate who could preserve the donor’s
rights and help in the decision making. Is there a need to
extend the role of the living liver donor advocate? If the
answer is positive, its role should be extended to not only living
kidney donor advocate, but also to DBD and DCD, for the
above reasons. If the answer is negative, or its role restricted to
living donor advocacy, it should not be a role of devil’s
advocate. Increasingly often, all transplant teams are con-
fronted with physicians who have no experience in transplan-
tation and donation, who do not themselves want to donate,
and who display wrong information regarding donation and
organ transplantation. These physicians, besides wrongly ex-
tending living liver donation risks to kidney living donation,
are not sensitive to donor rights, which includes the right to
donate. Therefore, and for that last reason, those physicians
must be separate from the donor advocacy role.
The last question is whether that role should be under-
taken by a psychologist or a psychiatrist in all circumstances.
It is good sense that close family members are not willing to
receive help from such persons when they want to save
children or relatives. By contrast, their help could be
valuable for a potential living donor with undirected un-
specified wishes of donation, the so-called “bon samarit-
ain.” In that situation, they will share the donor advocacy
role with the transplantation team.
The donor advocacy role must extend to all kinds of livingand DBD/DCD donation. Its complexity means that it wille undertaken by experienced persons in the field of
onation as well as transplantation, while always remem-
ering that the first donor right is the right to donate.
Kahlil Gibran, wrote about donation in The Prophet16:
Then said a richman, ‘Speak to us of Giving.’ . . . See first that
ou yourself deserve to be a giver, and an instrument of giving.
or in truth it is life that gives unto life—while you, who deem
ourself a giver, are but a witness. And you receivers—and you
re all receivers—assume no weight of gratitude, lest you lay a
oke upon yourself and upon him who gives.”
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